A pattern that bears watching is how quickly leaders now revise “big” economic threats—like Hormuz transit charges—while keeping the coercive instrument (the blockade) intact. Does that suggest the fee announcement was primarily signaling, or did pushback from insurers, Gulf partners, or legal advisers force a course correction ([BBC News], [SCMP])?
At the same time, Ebola response shows the inverse: logistics and trial protocols can move with surprising speed when high-capacity systems align, but that speed can amplify perceptions of inequity if local treatment capacity lags ([The Guardian]).
A competing interpretation is that these are unrelated cycles—war, markets, and medicine—coinciding rather than converging. The missing piece across them is still documentation: enforcement criteria at sea, access and casualty verification on the ground, and auditable public-health tracebacks.